Table 4.
Breakdown of the isolates by AMR class and sequencing platform at the decision gateways.
| Group Level 1 | Group Level 2 | Group Level 3 | ||||||
|---|---|---|---|---|---|---|---|---|
| Illumina | ONT | Illumina | ONT | Illumina | ONT | |||
| Carbapenem Susceptible | 55 | 50 | 3GC Susceptible | 37 | 28 | 3GC-susceptible | 37 | 28 |
| 3GC Resistant | 18 | 22 | Not ESBL or pAmpC | 1 | 4 | |||
| ESBL | 15 | 16 | ||||||
| pAmpC | 1 | 1 | ||||||
| ESBL & pAmpC | 1 | 1 | ||||||
| Carbapenem Resistant | 126 | 131 | Non-CP CRE | 25 | 38 | Non-CP CRE | 25 | 38 |
| CP CRE | 101 | 93 | KPC | 76 | 70 | |||
| MBL | 11 | 12 | ||||||
| OXA-48 | 10 | 8 | ||||||
| OXA-48 & MBL | 4 | 3 | ||||||